Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Assets (2016 - 2026)

Ironwood Pharmaceuticals' Return on Assets history spans 15 years, with the latest figure at 0.0% for Q4 2025.

  • On a quarterly basis, Return on Assets rose 1.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 1.0% increase, with the full-year FY2025 number at 0.0%, up 1.0% from a year prior.
  • Return on Assets hit 0.0% in Q4 2025 for Ironwood Pharmaceuticals, up from 0.0% in the prior quarter.
  • Over the last five years, Return on Assets for IRWD hit a ceiling of 0.01% in Q2 2021 and a floor of 0.03% in Q1 2024.
  • Historically, Return on Assets has averaged 0.0% across 5 years, with a median of 0.0% in 2022.
  • Biggest five-year swings in Return on Assets: decreased -3bps in 2023 and later rose 2bps in 2024.
  • Tracing IRWD's Return on Assets over 5 years: stood at 0.0% in 2021, then crashed by -53bps to 0.0% in 2022, then crashed by -1159bps to 0.02% in 2023, then soared by 81bps to 0.0% in 2024, then surged by 188bps to 0.0% in 2025.
  • Business Quant data shows Return on Assets for IRWD at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.01% in Q2 2025.